260 related articles for article (PubMed ID: 18621715)
1. A Cre-loxP-based mouse model for conditional somatic gene expression and knockdown in vivo by using avian retroviral vectors.
Seidler B; Schmidt A; Mayr U; Nakhai H; Schmid RM; Schneider G; Saur D
Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10137-42. PubMed ID: 18621715
[TBL] [Abstract][Full Text] [Related]
2. Production of avian retroviruses and tissue-specific somatic retroviral gene transfer in vivo using the RCAS/TVA system.
von Werder A; Seidler B; Schmid RM; Schneider G; Saur D
Nat Protoc; 2012 May; 7(6):1167-83. PubMed ID: 22635109
[TBL] [Abstract][Full Text] [Related]
3. Use of avian retroviral vectors to introduce transcriptional regulators into mammalian cells for analyses of tumor maintenance.
Pao W; Klimstra DS; Fisher GH; Varmus HE
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8764-9. PubMed ID: 12857957
[TBL] [Abstract][Full Text] [Related]
4. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
Lewis BC; Klimstra DS; Varmus HE
Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific induced DNA methyltransferase 1 (Dnmt1) in endocrine pancreas by RCAS-TVA-based somatic gene transfer system promotes β-cell proliferation.
Yuan Z; Gardiner JC; Maggi EC; Adem A; Zhang G; Lee S; Romanienko P; Du YN; Libutti SK
Cancer Gene Ther; 2019 Mar; 26(3-4):94-102. PubMed ID: 30190513
[TBL] [Abstract][Full Text] [Related]
6. A novel Flk1-TVA transgenic mouse model for gene delivery to angiogenic vasculature.
Vervoort VS; Lu M; Valencia F; Lesperance J; Breier G; Oshima R; Pasquale EB
Transgenic Res; 2008 Jun; 17(3):403-15. PubMed ID: 18027100
[TBL] [Abstract][Full Text] [Related]
7. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.
Du Z; Podsypanina K; Huang S; McGrath A; Toneff MJ; Bogoslovskaia E; Zhang X; Moraes RC; Fluck M; Allred DC; Lewis MT; Varmus HE; Li Y
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17396-401. PubMed ID: 17090666
[TBL] [Abstract][Full Text] [Related]
8. RCAS-mediated retroviral gene delivery: a versatile tool for the study of gene function in a mouse model of pancreatic cancer.
Mayr U; von Werder A; Seidler B; Reindl W; Bajbouj M; Schmid RM; Schneider G; Saur D
Hum Gene Ther; 2008 Sep; 19(9):896-906. PubMed ID: 18759559
[TBL] [Abstract][Full Text] [Related]
9. Using the RCAS-TVA system to model human cancer in mice.
Ahronian LG; Lewis BC
Cold Spring Harb Protoc; 2014 Nov; 2014(11):1128-35. PubMed ID: 25368315
[TBL] [Abstract][Full Text] [Related]
10. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
11. An in vivo model to study osteogenic gene regulation: targeting an avian retroviral receptor (TVA) to bone with the bone sialoprotein (BSP) promoter.
Li L; Zhu J; Tu Q; Yamauchi M; Sodek J; Karsenty G; Tang J; Chen J
J Bone Miner Res; 2005 Aug; 20(8):1403-13. PubMed ID: 16007338
[TBL] [Abstract][Full Text] [Related]
12. Soluble forms of the subgroup A avian leukosis virus [ALV(A)] receptor Tva significantly inhibit ALV(A) infection in vitro and in vivo.
Holmen SL; Salter DW; Payne WS; Dodgson JB; Hughes SH; Federspiel MJ
J Virol; 1999 Dec; 73(12):10051-60. PubMed ID: 10559319
[TBL] [Abstract][Full Text] [Related]
13. Development of a flexible and specific gene delivery system for production of murine tumor models.
Fisher GH; Orsulic S; Holland E; Hively WP; Li Y; Lewis BC; Williams BO; Varmus HE
Oncogene; 1999 Sep; 18(38):5253-60. PubMed ID: 10498877
[TBL] [Abstract][Full Text] [Related]
14. Intronic deletions of tva receptor gene decrease the susceptibility to infection by avian sarcoma and leukosis virus subgroup A.
Chen W; Liu Y; Li H; Chang S; Shu D; Zhang H; Chen F; Xie Q
Sci Rep; 2015 Apr; 5():9900. PubMed ID: 25873518
[TBL] [Abstract][Full Text] [Related]
15. Conditional expression of the TVA receptor allows clonal analysis of descendents from Cre-expressing progenitor cells.
Beier KT; Samson ME; Matsuda T; Cepko CL
Dev Biol; 2011 May; 353(2):309-20. PubMed ID: 21397594
[TBL] [Abstract][Full Text] [Related]
16. An RCAS-TVA-based approach to designer mouse models.
Orsulic S
Mamm Genome; 2002 Oct; 13(10):543-7. PubMed ID: 12420130
[No Abstract] [Full Text] [Related]
17. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
[TBL] [Abstract][Full Text] [Related]
18. Novel monoclonal antibody directed at the receptor binding site on the avian sarcoma and leukosis virus Env complex.
Ochsenbauer-Jambor C; Delos SE; Accavitti MA; White JM; Hunter E
J Virol; 2002 Aug; 76(15):7518-27. PubMed ID: 12097564
[TBL] [Abstract][Full Text] [Related]
19. RCAS/SCL-TVA animal model allows targeted delivery of polyoma middle T oncogene to vascular endothelial progenitors in vivo and results in hemangioma development.
Sausville J; Molinolo AA; Cheng X; Frampton J; Takebe N; Gutkind JS; Feldman RA
Clin Cancer Res; 2008 Jun; 14(12):3948-55. PubMed ID: 18559617
[TBL] [Abstract][Full Text] [Related]
20. Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein.
Snitkovsky S; Young JA
Virology; 2002 Jan; 292(1):150-5. PubMed ID: 11878917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
